All posts from Zacks
Zacks in Our Research. Your Success.,

CME Group (CME) Q2 Earnings Top, Revenues Lag, Expenses Fall

CME Group Inc. CME reported second-quarter 2017 adjusted earnings per share of $1.23, beating the Zacks Consensus Estimate of $1.20. The bottom line also increased 7.9% year over year.

Results were primarily driven by lower expenses. The quarter witnessed a record average daily volume (ADV).

CME Group Inc. Price, Consensus and EPS Surprise

Including one-time items, the net income was $1.22 per share, up 32% year over year.

Performance in Detail

CME Group’s revenues of $925 million increased 2.1% year over year. However, the reported figure missed the Zacks Consensus Estimate of $930 million. Improvement in revenues may be attributable to higher clearing and transaction fees, plus access and communication fees.

Total expenses decreased 7% year over year to $319 million during the reported quarter.

Operating income improved about 7.5% to $605.6 million from the prior-year quarter.

Average daily volume (ADV) rose 9% year over year to a record 16.5 million contracts, with growth registered across four of the six product lines. Average rate per contract increased in three of the six product lines.

Financial Update

As of Jun 30, 2017, CME Group had $1.4 billion of cash and marketable securities, down 26% from year-end 2016. As of Jun 30, 2017, the long-term debt of $2.2 billion inched up 0.04% from the last year-end figure.

As of Jun 30, 2017, the company had total assets worth $78.5 billion, up from $69.4 billion at year-end 2016.

The company paid dividends worth $223 million in the reported quarter.

Our Take

CME Group’s results reflect a solid performance. The company remains well-positioned for growth, given its strong market position with diverse derivative product lines. Efforts to expand and cross-sell core exchange-traded business through strategic alliances & acquisitions, new product initiatives and global reach, support growth. However, escalating costs and stiff competition remain key challenges.

Currently, CME Group carries a Zacks Rank # 3 (Hold). You can see _1link">the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Companies in Securities Exchange Industry

MarketAxess Holdings Inc. MKTX and Nasdaq, Inc. NDAQ beat their respective Zacks Consensus Estimate in the second quarter.

Intercontinental Exchange Inc. ICE will report second-quarter results on Aug 3 before the market opens.

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report
CME Group Inc. (CME): Free Stock Analysis Report
Nasdaq, Inc. (NDAQ): Free Stock Analysis Report
MarketAxess Holdings, Inc. (MKTX): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research